Condition
Estrogens
Total Trials
5
Recruiting
0
Active
0
Completed
5
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
20%
1 of 5 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
1Total
P 2 (1)
Trial Status
Completed5
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06925633Completed
Estrogen Levels and Postoperative Recovery in IVF Patients
NCT03528902Phase 2Completed
Tamoxifen Therapy to Treat Pulmonary Arterial Hypertension
NCT02951949Completed
Estrogen Exposure and Atherosclerosis in Postmenopausal Women
NCT02434562Completed
Development and Validation of in Vitro Cell-based Bioassays for Nuclear Receptor Activation
NCT00264407Completed
Neural Changes in the Aging Auditory System
Showing all 5 trials